medigraphic.com
ISSN 2007-6509 (Impreso)
Órgano oficial de la Asociación Mexicana de Medicina Transfusional A.C.

2011, Número 2

<< Anterior Siguiente >>

Rev Mex Med Transfus 2011; 4 (2)


Medicina regenerativa y terapia celular

Benítez AG

Idioma: Español
Referencias bibliográficas: 47
Paginas: 70-77
Archivo PDF: 75.08 Kb.


RESUMEN

En el último siglo, los avances en la biología han permitido el desarrollo de la medicina regenerativa y la terapia celular; en el presente artículo se discuten brevemente las diferentes formas de terapia celular y su relación con la medicina regenerativa, así como los potenciales a corto y mediano plazo que tienen éstas.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Meyer U, Handschel J, Meyer T, Handschel J, Wiesmann H P. Fundamentals of tissue engineering and regenerative medicine. Berlin, Alemania. Ed. Springer. 2009.

  2. Atala A, Lanza R, James T, Nerem R. Foundations of regenerative medicine. Canada. Ed. Academic Press. Elsevier, 2010.

  3. Halme DG, Kessler DA. FDA regulation of Stem-Cell–Based therapies. N Engl J Med 2006; (19); 355 (16): 1730-1735.

  4. Haseltine WA. The emergence of regenerative medicine: a new field and a new society. J Regen Med 2001; 2 (4): 17.

  5. Mason C, Dunnill P. A brief definition of regenerative medicine. Regen Med 2008; 3 (1): 1-5.

  6. Maienschein J. Regenerative medicine’s historical roots in regeneration, transplantation and translation. Dev Biol (2010), doi:10.1016/j.ydbio.2010.06.014

  7. Cambell NA, Reece JB, Molles M, Urry L, Heyden R. Biología. 7a Ed. Madrid España. Ed. Médica Panamericana, 2007.

  8. Regenerative Medicine-Glossary. British Standards 2008. © BSI 2008.

  9. Rodríguez-Pardo VA. Células madre: Conceptos generales y perspectivas de investigación. Universitas Scientiarum 2005; l 10 (1): 5-14.

  10. Bongso A, Richards M. History and perspective of stem cell research. 2004; 18 (6): 827-842.

  11. Walker MR, Patel KK, Stappenbeck TS. The stem cell niche. J Pathol 2009; 217: 169-180.

  12. Ehninger A, Trumpp A. The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J Exp Med 2011; 14; 208 (3): 421-8.

  13. Kiefer JC. Primer and interviews: The dynamic stem cell niche. Dev Dyn 2011; 240 (3): 737-43.

  14. Borovski T, De Sousa E, Melo F, Vermeulen L, Medema JP. Cancer stem cell niche: the place to be. Cancer Res 2011; 1; 71 (3): 634-9.

  15. http://www.fda.gov/cber/guidelines.htm. Guidance for Industry Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps).

  16. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline /2009/09/WC500003898.pdf. Guideline on Human Cell-Based Medicinal Products

  17. Nelson T J, Behfar A, Terzic A. Strategies for therapeutic repair: The “R3” regenerative medicine paradigm clinical and translational. Science 2008; 1 (2):168-171.

  18. Appelbaum FR. Hematopoietic-Cell transplantation at 50. N Engl J Med 2007; 357 (15): 1472-1475.

  19. Chan AC, Carter PJ. Therapeutic antibodies for autoimmunity and inflammation. Nature reviews immunology 2010; 10 (301): 301-316.

  20. Weiner L M, Surana R, Wang S. Monoclonal antibodies: versatile platforms for cancer immunotherapy nature reviews immunology 2010; 10 (301): 317-327.

  21. Pardoll D. Timeline: a decade of advances in immunotherapy nature medicine 2011; 17 (3): 296.

  22. Scudellari M. A ballsy search for cancer targets. Nature Medicine 2011; 17: 916-918.

  23. Hilkens CM, Isaacs JD, Thomson AW. Development of dendritic cell-based immunotherapy for autoimmunity. Int Rev Immunol 2010; 29 (2): 156-83.

  24. Manicassamy S, Pulendran B. Dendritic cell control of tolerogenic responses. Immunol Rev 2011; 241 (1): 206-27.

  25. Javed F, Al-Askar M, Al-Rasheed A, Al-Hezaimi K. Significance of the platelet-derived growth factor in periodontal tissue regeneration. Arch Oral Biol 2011; 19:.

  26. Cervelli V, Gentile P, Scioli MG, Grimaldi M, Casciani CU. Application of platelet-rich plasma in plastic surgery: Clinical and in vitro evaluation tissue engineering; part C 2009; 15 (00): 1-10

  27. de Leon JM, Driver VR, Fylling CP, Carter MJ, Anderson C et al. The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma gel. Adv Skin Wound Care 2011; 24 (8): 357-368.

  28. Lyras DN, Kazakos K, Verettas D, Polychronidis A, Tryfonidis M et al. The influence of platelet-rich plasma on angiogenesis during the early phase of tendon healing. Foot Ankle Int 2009; (11): 1101-6.

  29. Cai J, Weiss ML, Rao. In search of “stemness”. MS Experimental Hematology 2004; 32: 585-598.

  30. Nelson TJ, Martínez-Fernández A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 2009; 120 (5): 408-16.

  31. Burt RK, Loh Y, Pearce W, Beohar N, Barr WG et al. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 2008; 299 (8): 925-36.

  32. Savitz SI, Chopp M, Deans R, Carmichael ST, Phinney D, Wechsler L. Stem cell therapy as an emerging paradigm for stroke (STEPS) II. Stroke 2011; 42 (3): 825-9.

  33. Borlongan CV, Weiss MD. Baby STEPS: a giant leap for cell therapy in neonatal brain injury. Pediatr Res 2011; 70 (1): 3-9.

  34. Bhanot Y, Rao S, Ghosh D, Balaraju S, C R R, K V SK. Autologous mesenchymal stem cells in chronic spinal cord injury. Br J Neurosurg 2011; 25 (4): 516-22.

  35. Mason C, Manzotti E. Regenerative medicine cell therapies: numbers of units manufactured and patients treated between 1988 and 2010. Regenerative Medicine 2010; 5 (3): 307-313.

  36. Vemuri MC, Chase LG, Rao MS. Mesenchymal stem cell assays and applications. Methods Mol Biol 2011; 698: 3-8.

  37. Rama P, Matuska S, Paganoni G, Spinelli A, De Luca M, Pellegrini G. Limbal stem-cell therapy and long-term corneal regeneration N Engl J Med 2010; 363: 147-55.

  38. Kay MA. State-of-the-art gene-based therapies: the road ahead. Nat Rev Genet 2011; 12 (5): 316-28.

  39. Boztug K, Schmidt M, Schwarzer A, Banerjee PP, Avedillo Diez I et al. Stem-Cell gene therapy for the Wiskott-Aldrich syndrome. N Engl J Med 2010; 363: 1918-27.

  40. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126 (4): 663-76.

  41. Douglas RH. A new dawn for stem-cell therapy. N Engl J Med 2008; 358: 964-966.

  42. Moretti A, Bellin M, Welling A, Jung CB, Lam JT et al. Patient-specific induced pluripotent stem-cell models for Long-QT syndrome. N Engl J Med 2010; 363: 1397-1409.

  43. Guidelines for the Clinical Translation of Stem Cells 2008. Ed International Society Stem Cell Research.

  44. www.diputados.gob.mx/LeyesBiblio/pdf/142.pdf

  45. http://pewforum.org/docs/index.php?docid=318

  46. Sipp D. Stem cell stratagems in alternative medicine Regen. Med 2011; 6 (3): 407-414.

  47. Watson PH, Wilson-McManus-JE, Barnes R, Giesz SC, Png A. Evolutionary concepts in biobanking - the BC BioLibrary. Journal of Translational Medicine 2009; 7: 95.




2020     |     www.medigraphic.com